Loxo Oncology Inc. (LOXO) Stock Price, Quote, News and Overview
NASDAQ:LOXO - Nasdaq -
LOXO Quote, Performance and Key Statistics
234.66
-0.07 (-0.03%)
The current stock price of LOXO is 234.66 null. In the past month the price increased by 0.6%. In the past year, price increased by 123.91%.
About LOXO
Company Profile
Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.
Company Info
Loxo Oncology Inc.
281 TRESSER BOULEVARD 9TH FLOOR
STAMFORD CT 06901
CEO: Joshua H. Bilenker
Phone: 203-653-3880
Loxo Oncology Inc. / LOXO FAQ
What is the stock price of Loxo Oncology Inc. today?
The current stock price of LOXO is 234.66 null. The price decreased by -0.03% in the last trading session.
What is the ticker symbol for Loxo Oncology Inc. stock?
The exchange symbol of Loxo Oncology Inc. is LOXO and it is listed on the Nasdaq exchange.
On which exchange is LOXO stock listed?
LOXO stock is listed on the Nasdaq exchange.
What is Loxo Oncology Inc. worth?
Loxo Oncology Inc. (LOXO) has a market capitalization of 7.18B null. This makes LOXO a Mid Cap stock.
What are the support and resistance levels for Loxo Oncology Inc. (LOXO) stock?
Loxo Oncology Inc. (LOXO) has a support level at 234.6 and a resistance level at 234.67. Check the full technical report for a detailed analysis of LOXO support and resistance levels.
Should I buy Loxo Oncology Inc. (LOXO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LOXO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LOXO, evaluating the profitability, health, valuation and growth aspects
- Loxo Oncology Inc. (LOXO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Loxo Oncology Inc. (LOXO) Sales and EPS estimates to see what analysts future expectations are.
- Loxo Oncology Inc. (LOXO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Loxo Oncology Inc. (LOXO) Insider and Institutional Ownership to learn about the owners and their transactions.
- Loxo Oncology Inc. (LOXO) Stock Chart to make your own analysis
- Loxo Oncology Inc. (LOXO) Latest news and press-releases to stay up to date.
Does Loxo Oncology Inc. (LOXO) stock pay dividends?
LOXO does not pay a dividend.
What is the Price/Earnings (PE) ratio of Loxo Oncology Inc. (LOXO)?
Loxo Oncology Inc. (LOXO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.09).
LOXO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to LOXO. When comparing the yearly performance of all stocks, LOXO is one of the better performing stocks in the market, outperforming 98.8% of all stocks.
LOXO Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LOXO. LOXO has an average financial health and profitability rating.
LOXO Financial Highlights
Over the last trailing twelve months LOXO reported a non-GAAP Earnings per Share(EPS) of -2.09. The EPS increased by 53.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -50.99% | ||
| ROA | -9.55% | ||
| ROE | -16.61% | ||
| Debt/Equity | 0 |